A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas Article / By Wiley Knowledge Hub A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas Read More »
Exploring the landscape of immunotherapy approaches in sarcomas Article / By Wiley Knowledge Hub Exploring the landscape of immunotherapy approaches in sarcomas Read More »
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma Article / By Wiley Knowledge Hub Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma Read More »
ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma Article / By Wiley Knowledge Hub ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma Read More »
Activity of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma Article / By Wiley Knowledge Hub Activity of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma Read More »
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma Article / By Wiley Knowledge Hub Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma Read More »
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma Article / By Wiley Knowledge Hub Established and Experimental Systemic Treatment Options for Advanced Liposarcoma Read More »
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis Article / By Wiley Knowledge Hub First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis Read More »
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial Article / By Wiley Knowledge Hub Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial Read More »
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study Article / By Wiley Knowledge Hub Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study Read More »
